Instructions to the author
All clinical trials from India must be registered with “clinical trials registry – India”. The trials conducted outside India may be registered with any other clinical trial registry. We recommend and making it mandatory to have registration number for all clinical trials submitted for publication from January 2020.
The manuscripts will be reviewed for possible publication with the understanding that they are being submitted to one journal at a time and have not been published, simultaneously submitted or already accepted for publication elsewhere. The manuscripts are rejected by the editorial office before a formal peer-review.
The Editorial office review all submitted manuscripts initially. Manuscripts with insufficient originality, serious scientific and technical flaws or lack of a significant message are rejected. All manuscripts received are duly acknowledged. Manuscripts are sent to two or more expert reviewers without revealing the identity of the contributors to the reviewers. Each manuscript is also assigned to a member of the editorial team, who based on the comments from the reviewers takes a final decision on the manuscript. The contributors will be informed about the reviewers’ comments and acceptance/rejection of the manuscript. The average submission to first decision time is about 3-4 weeks and about 65-70% of unsolicited manuscripts do not get published.
Articles accepted would be copy edited for grammar, punctuation, print style, and format. Page proofs will be sent to the corresponding author, which has to be returned within three days. Correction received after that period may not be included.
Authorship credit should be based only on substantial contributions
Conditions 1, 2 and 3 must be met. Participation solely in the acquisition of funding or the collection of data does not justify authorship. General supervision of the research group is not sufficient for authorship. Each contributor should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. The order of naming the contributors should be based on the relative contribution of the contributor towards the study and writing the manuscript. Once submitted the order cannot be changed without the written consent of all the contributors.
For a study from in a single institute, the number of contributors should not exceed seven. For a case-report, brief communication, letter to the editor and review article the number of contributors should not exceed five. A justification should be included if the number of contributors exceeds these limits. Two/three additional authors from other departments/specialties would be permissible if they have contributed significantly.
Only those who have done substantial work in a particular field can write a review article. A short summary of the work done by the contributor(s) in the field of review should accompany the manuscript. The journal expects the contributors to give post-publication updates on the subject of review. The update should be brief, covering the advances in the field after the publication of the article and should be sent as a letter to the editor, as and when major development occurs in the field.
Contributors should provide a description of what each of them contributed towards the manuscript. Description should be divided in following categories, as applicable: concepts, design, definition of intellectual content, literature search, clinical studies, experimental studies, data acquisition, data analysis, statistical analysis, manuscript preparation, manuscript editing and manuscript review. Author’s contributions will be printed on the first page of the article. One or more author should take responsibility of the integrity of the work as a whole from inception to published article and should be designated as ‘guarantor’.
All authors of submitting articles to the journal must disclose any conflict of interest they may have with an institution or product that is mentioned in the manuscript and/or is important to the outcome of the study presented. Authors should also disclose conflict of interest with products that compete with those mentioned in their manuscript. The Editor will discuss with the authors on an individual basis the method by will be communicated to the readers.
Statement of Human Rights: When reporting studies that involve human participants, authors should include a statement that the studies have been approved by the appropriate institutional and national research ethics committee and have been performed in accordance with the ethical standard as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. The author must explain the reasons for their approach and demonstrate that the independent ethics committee or institutional review board explicitly approved the doubtful aspects of the study. If the study was granted exemption from requiring ethics approval, this should also be detailed in the manuscript (including the name of the ethics committee that granted the exemption and the reasons for the exemption).
Statement on the Welfare of Animals Rights
When animals used for research must be respected in reporting experiments on animals, authors should indicate where the national and international institutional guidelines for the care ad use of animals have been followed, and that the studies have been approved by a research ethics committee at the institution or practice at which the studies were conducted. Please provide the name of the ethics committee and the relevant permit number.
If articles do not contain studies with human participants or animals by any of the authors, the statement should be as below:
Ethical approval: This article does not contain any studies with human and animal participants and performed by any of the authors.
To reproduce published material, and to use illustrations or report information about identifiable people a copy of the permission obtained must accompany the manuscript. Copied of any and all published articles or other manuscripts in preparation or submitted elsewhere that are related to the manuscript must also accompany the manuscript.
All manuscripts must be submitted on-line through the website http://innovpub.org/ First-time users please click the Register button from the main menu and enter the requested information. On successful registration, you will be sent an email indicating your user name and password. Print a copy of this information for future reference. If you have received an email from us with an assigned user ID and password, or if you are a repeat user, do not register again. Just log in. Once you have an assigned ID and password, re-registration is unnecessary, even if your status changes (that is, author, reviewer, or editor in chief). You will be able to track the progress of your manuscript through the system. If you face any problem please contact editorial office +91-11-61364114, 61364115, or email id: email@example.com
The contributor may provide names of two or three qualified reviewers who have had experience in the subject of the submitted manuscript, but who are not affiliated with the same institutes as the contributor/s. However, the selection of these reviewers is the sole discretion of the editorial office policy.
When you submit an article, the following items must be included. Manuscripts that do not adhere to the following instructions will be returned to the corresponding author for technical revision before undergoing peer review.
The contributor’ form and copyright transfer form (template provided below) has to be submitted in original with the signatures of all the contributors within fifteen days of confirmation from submission via courier, post or email as a scanned image. Hard copies of the images (one set) with high resolution and good contrast, for articles submitted online, should be sent to the journal office only.
A. Title Page
The Title page should carry
B. Abstract Page
The second page should carry the full title of the manuscript and an abstract (of no more than 150 words for brief report and 250 words for original articles and other article types). The abstract should be structured for original articles. State the context (background), aims, settings and design, material and methods, statistical analysis used, results and conclusions. Below the abstract should provide 3 to 8 keyword, arranged alphabetically. The abstract should not be structured for a brief report, review article, brief communication and research methodology. Don’t consider reference in abstract.
State the purpose and summarize the study or observation.
D. Materials and Methods
The Methods section should only include information that was available at the time the study was planned or protocol written; all information obtained during the conduct of the study belongs to the results section.
Selection and Description of Participants: Describe your selection of the observational or experimental participants (patients or laboratory animals, including controls) clearly, including eligibility and exclusion criteria and a description of the source population. Because the relevance of such variables as age and sex to the object of research is not always clear, authors should explain their use when they are included in a study repot; for example, authors should explain why only subjects of certain ages were included or why women were excluded. The guiding principle should have clarity about how and why a study was done in a particular way. When authors use variables such as race or ethnicity, they should define how they measured the variables and justify their relevance.
Technical information: Identify the methods, apparatus (give the manufacture’s name and address in parentheses), and procedures in sufficient detail to allow other workers to reproduce the results. Give references to established methods, including statistical methods (see below); provide references and brief descriptions for methods that have been published but are not well known: describe new or substantially modified methods, give reasons for using them, and evaluate their limitations. Identify precisely all drugs and chemicals used, including generic name(s), dose(s), and route(s) of administration.
Reports of randomized clinical trials should present information on all major study elements, including the protocol, assignment of interventions (methods of randomization, concealment of allocation to treatment group), and the method of masking (blinding) based on the CONSORT Statement (http://www.consort-statement.org).
Reporting Guidelines for Specific Study Designs
Type of Study
Randomized controlled trials
Studies of diagnostic accuracy
Systematic reviews and meta-analyses
Systemic Reviews and Meta Analyses
Meta-analysis of observational studies in epidemiology
When reporting studies on human indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the Helsinki Declaration of 1975, as revised in 2000 (available at https://www.wma.net/what-we-do/education/medical-ethics-manual/). Do not use patients’ names, initials, or hospital numbers, especially in illustrative material. When reporting experiments on animals, indicate whether the institution’s or a national research council’s guide for, or any national law on the care and use of laboratory animals was followed.
Evidence for approval by a local Ethics Committee (for both human as well as animal studies) must be supplied by the authors on demand. Animal experimental procedures should be as humane as possible and the details of anesthetics and analgesics used should be clearly stated. The ethical standards of experiments must be in accordance with the guidelines provided by the CPCSEA (animal) and ICMR (human). The journal will not consider any paper which is ethically unacceptable. A statement on ethics committee permission and ethical practices must be included in all research articles under the Materials and Methods’ section.
Whenever possible quantify findings and present them with appropriate indicators of measurement error or uncertainty (such as confidence intervals). Report losses to observation (such as dropouts from a clinical trial). When data are summarized in the Results section, specify the statistical methods used to analyze them. Avoid non-technical uses of technical terms in statistics, such as ‘random’ (which implies a randomizing device), ‘normal’, ‘significant’, ‘correlations’, and ‘sample’. Define statistical terms, abbreviations, and most symbols. Specify the computer software used. Use upper italics (P 0.048). For all P values include the exact value and not less than 0.05 or 0.001.
Present your results in a logical sequence in the text, tables, and illustrations, giving the main or most important finding first. Do not repeat in the text all the data in the tables or illustrations; emphasize or summarize only important observations. Extra or supplementary materials and technical detail can be place in an appendix where it will be accessible but will not interrupt the flow of the text; alternatively, it can be published only in the electronic version of the journal.
When data are summarized in the Results section, give numeric results not only as derivatives (for example, percentages) but also as the absolute numbers from which the derivatives were calculated, and specify the statistical methods used to analyze them. Restrict tables and figures to those needed to explain the argument of the paper and to assess its support. Use graphs as an alternative to tables with many entries; do not duplicate data in graphs and tables. “Where scientifically appropriate, analyses of the data by variables such as age and sex should be included.
Include summary of key findings (primary outcome measures, secondary outcome measures, results as they relate to a prior hypothesis); Strengths and limitations of the study (study question, study design, data collection, analysis and interpretation); Interpretation and implications in the context of the totality of evidence (is there a systematic review to refer to, if not could one be reasonably done here and now?, what this study adds to the available evidence, effects on patient care and health policy, possible mechanism); Controversies raised by this study; and Future research directions (for this particular research collaboration, underlying mechanisms, clinical research).
Do not repeat in detail data or other material given in the Introduction or the Results section. In particular, contributors should avoid making statements on economic benefits and costs unless their manuscript includes economic data and analysis. Avoid claiming priority and alluding to work that has not been completed. State new hypotheses when warranted, but clearly label them as such.
References should be numbered consecutively in the order in which they are first mentioned in the text (not in alphabetic order). Identify references in text, tables, and legends by numerals in superscript after the punctuation marks. References cited only in tables or figure legends should be numbered in accordance with the sequence established by the first identification in the text of the particular table or figure. Use the style of the examples below, which are based on the formats used by the NLM in Index Medicus. The titles of journals should be abbreviated according to the style used in Index Medicus. Use complete name of the journal for non-indexed journals. Avoid using abstracts as references. Information from manuscripts submitted but not accepted should be cited in the text as ‘unpublished observations” with written permission from the source; Avoid citing a “personal communication” unless it provides essential information not available from a public source, in which case the name of the person and date of communication should be cited in parentheses in the text. Use ‘Check References’ facility available in the website to correct the references. Avoid citing text book references and very old references. This reduces the credibility of the article.
The commonly cited types of references are shown here for other types of references such as electronic media; newspaper items, etc. please refer to ICMJE Guidelines (http://www.icmje.org/about-icmje/ or
Articles in Journals
List the first six contributors followed by et al. There should not be any gaps between the year;volume:page-page.
Kulkarni C, Mohan Metri R. Comparison of nuclear size in mature and hypermature cataract. Indian J Clin Exp Ophthalmol 2019;5(4):426-431.
K. illustrations (Figures)
Include clinical and imagine photographs in the article to have better impact on the readers.
A credit line should appear in the legend for such figures
Case report must meet all of the following criteria:
Preparation of Case Report
Follow the standard format for the article (Abstract, Key-words, Introduction, Cases History, Discussion and References).
Images and Letter to the Editor
Abstract and key words are not required. Text should be a running text with brief report and short discussion. Only 5 latest references are permitted.
While submitting a revised manuscript, Authors / contributors are requested to include, the ‘references’ remarks along with point to point clarification at the beginning in the revised file itself. In addition, mark the changes as underlined or colored text in the article. A photocopy of the first page of all the cited references (articles and books) can be asked by the journal to verify the references.
Journal provides no free printed reprints. Authors can purchase reprints, payment for which should be done at the time of submitting the author proofs.
JPMHH follows an Open Access Policy allowing unrestricted online access to all its content and journal not depends on any external grant or advertisement income from any public or private source to support the journal publication.
Note: We do not charge any Article Submission / Processing / Publication fee.
Data availability statements provide a standardized format to describe the availability of data underlying the research results of the article. The statement may refer to original data generated in the course of the study or to third-party data analyzed in the article. The statement should describe and provide means of access, where applicable by linking to the data or providing the required unique identifier. Data are available in a repository and can be accessed via a DOI link , data are available in a repository and can be accessed using a unique identifier other than a DOI are available in the GenBank Nucleutide database at accession number, deposition number.
Please see the Instructions to Authors of your chosen journal for their specific requirements in relation to Data Availability Statements.
Identifying information should not be published in written descriptions, photographs, sonograms, CT scans, etc., and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian, wherever applicable) gives informed consent for publication. The authors should remove patients’ names from figures unless they have obtained informed consent from the patients. The journal abides by ICMJE guidelines:
The journal is protected under terms of the Creative Commons Attribution 4.0 International (CC BY 4.0) license (https://creativecommons.org/licenses/by/4.0/) which allows others to reuse, copy and redistribute the material in any medium or format, and to alter or transform it, even commercially, as long as the author and original source are properly cited.
Presentation and format
Language and Grammar
Tables and Figures
Simply plagiarism has been traditionally defined as the taking of words, images, ideas, etc. from an author and presenting them as one’s own. It is often associated with phrases, such as the kidnapping of words, the kidnapping of ideas, fraud, and literary theft. Plagiarism can manifest itself in a variety of ways and it is not just confined to student papers or published articles or books. For example, consider a scientist who makes a presentation at a conference and discusses at length an idea or concept that had already been proposed by someone else and that is not considered common knowledge. During his presentation, he fails to fully acknowledge the specific source of the idea and, consequently, misleads the audience into thinking that he was the originator of that ideas. This, too, may constitute an instance of plagiarism.
Open access policy indicate that articles published as online can be freely accessed at journal archives website by all users. All articles publish as gold open access which will be immediately and permanently free for everyone to read and download. We offer authors a choice of user licenses, which define the permitted reuse, licenses allow readers to copy and redistribute the material in any medium or format, and to alter, transform, or build upon the material, including for commercial use, providing the original author is credited. Our focus on robust and insightful research, supporting the development of new areas of knowledge and making ideas and information accessible around the globe
Making the research publicly available to everyone and free of charge and without most copyright and licensing restrictions will accelerate scientific research, efforts and allow authors to reach a large number of readers reference:
All submissions and publication in the journal are assumed to be the product of honesty observations. While submission the corresponding author take full responsibility for the integrity of the work as a whole, from inception to the published article. If substantial doubts arise regarding the scientific integrity of any submission or publication it is the responsibility of the editor to pursue these issues with the author. Corresponding author are responsible for communication with editorial office on issues of scientific misconduct or the retraction of a published manuscript, should questions of this type arise. If Issue of scientific integrity cannot be resolved with the authors to the satisfaction of the editor, they will be referred to the institution where the work was done and the author funding agency for further investigation. If work is found to be fraudulent will print a retraction, preferably signed by all authors of the work in question. The editor reserve the right to initiate the retraction of a published manuscript, should it be deemed appropriate. Alternatively, the editor may publish to print an expression of concern regarding the work, with and explanation.
Innovative Publication follow COPE retraction guidelines and also refers to the ICMJE advice on Corrections, Retractions and “Expression of Concern” as well as on overlapping publication. Journal allow author(s) to retain publishing rights without restrictions and the author to hold the copyright without restrictions.
Digital content is stored in the CLOCKSS / PKP PN archive with no user access unless a ‘Trigger’ event occurs. The CLOCKSS / PKP PN archives policy and regularly check the validity of stored data and preserves it for the long term which is available from our archive via open access.
Articles in Press are peer reviewed, accepted articles to be published in this publication. When the final article is assigned to the volume/issues of the publication, the Article in Press version will be removed and the final version will appear in the associated published volumes/issues of the publication. Please be aware that, although Articles in Press do not have all bibliographic details yet, they can already be cited using the year of online publication and the DOI.
Below are the template given as per journal requirements. Authors Can use this for his/her manuscript.